. http://lm360.us/Svay-father-of-Matusz-from-Poznan?Laurogran=266 eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. . . advertisement .lawmakers should revisit that idea when lepage is no longer in office next year. . sign in to get notified via email when new comments are made. .aubrey: but with two young children and a busy schedule, she's come to appreciate the frozen food aisle. . . share or comment on this article: .